Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (143) 143
Newspaper Article (86) 86
Patent (10) 10
Dissertation (2) 2
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49) 49
animals (28) 28
neurosciences (25) 25
male (24) 24
rats (17) 17
rats, sprague-dawley (16) 16
dopamine (14) 14
humans (14) 14
microdialysis (13) 13
biochemistry & molecular biology (12) 12
chemistry (12) 12
mice (11) 11
female (10) 10
neurons (10) 10
antioxidants (9) 9
human necessities (9) 9
organic chemistry (9) 9
chemistry, multidisciplinary (8) 8
dopamine - metabolism (8) 8
analysis (7) 7
behavioral sensitization (7) 7
cell biology (7) 7
hygiene (7) 7
medical or veterinary science (7) 7
medicine, general & internal (7) 7
middle aged (7) 7
phenols (7) 7
alzheimer's disease (6) 6
alzheimers-disease (6) 6
amphetamine (6) 6
biochemistry (6) 6
cocaine (6) 6
drug administration schedule (6) 6
expression (6) 6
metallurgy (6) 6
nucleus-accumbens (6) 6
preparations for medical, dental, or toilet purposes (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
adult (5) 5
agriculture, multidisciplinary (5) 5
cancer (5) 5
chemistry, organic (5) 5
chemistry, physical (5) 5
education & educational research (5) 5
enzymes (5) 5
hippocampus (5) 5
in-vivo (5) 5
mice, inbred c57bl (5) 5
multidisciplinary sciences (5) 5
neuroprotection (5) 5
nucleus accumbens (5) 5
peptides (5) 5
physiological aspects (5) 5
prefrontal cortex (5) 5
time factors (5) 5
toxicity (5) 5
ventral tegmental area (5) 5
activation (4) 4
aged (4) 4
antioxidant (4) 4
article (4) 4
brain (4) 4
brain - metabolism (4) 4
chemical properties (4) 4
derivatives (4) 4
diabetes (4) 4
education, scientific disciplines (4) 4
education, special (4) 4
fruit (4) 4
glutamate (4) 4
identification (4) 4
incidence (4) 4
law (4) 4
locomotor sensitization (4) 4
motor activity - drug effects (4) 4
neurons - drug effects (4) 4
neurons - metabolism (4) 4
neurotransmission (4) 4
pc12 cells (4) 4
pharmacology & pharmacy (4) 4
phenolic compounds (4) 4
plant extracts - pharmacology (4) 4
polyphenols (4) 4
prevalence (4) 4
prospective studies (4) 4
proteins (4) 4
receptors (4) 4
release (4) 4
risk (4) 4
risk factors (4) 4
rodents (4) 4
surgery (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
acids (3) 3
addiction (3) 3
agriculture (3) 3
alkaloids (3) 3
animal-model (3) 3
antigens (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
by Gerstein, Hertzel C and Colhoun, Helen M and Dagenais, Gilles and Dagenais, Gilles R and Diaz, Rafael and Diaz, Sarahy and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Riesmeyer, Jeffrey S and Riddle, Matthew C and Rydén, Lars and Xavier, Denis and Atisso, Charles Messan and Dyal, Leanne and Hall, Stephanie and Hall, Charles and Rao-Melacini, Purnima and Wong, Gloria and Avezum, Alvaro and Basile, Jan and Chung, Ming-Min and Chung, Namsik and Chung, Jin-Wook and Conget, Ignacio and Cushman, William C and Franek, Edward and Hancu, Nicolae and Hanefeld, Christoph and Hanefeld, Markolf and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Keltai, Katalin and Lanas, Fernando and Leiter, Lawrence A and Lopez-Jaramillo, Patricio and Cardona Munoz, Ernesto German and Pirags, Valdis and Pogosova, Nana and Raubenheimer, Peter J and Shaw, Jonathan E and Sheu, Wayne H-H and Temelkova-Kurktschiev, Theodora and Abella, Mercedes and Alebuena, Andrea and Almagro, Sandra and Amoroso, Eduardo and Anadon, Paula and Andreu, Elizabeth and Aristimuño, Guillermo and Arzadun, Maria and Barbieri, Maria and Barcudi, Raul and Bartolacci, Ines and Bolobanich, Gabriel and Bordonava, Anselmo and Bustamante Labarta, Miguel and Bustos, Betina and Caccavo, Alberto and Camino, Alejandra and Cantero, Maria and Carignano, Maria and Cartasegna, Luis and Cipullo, Marcela and Commendatore, Víctor and Conosciuto, Victoria and Costamagna, Osvaldo and Crespo, Claudia and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dean, Sofia and Dituro, Claudio and Dominguez, Andrea and Farah, Miguel and Fernandez, Alberto and Fernandez, Florencia and Ferrari, Adriana and Flammia, Patricia and Fuentealba, Jose and Gallardo, Karina Beatriz and Garcia, Mar and Garcia, Celso and Garcia, Maria and Garcia Duran, Ruben and Garrido, Marcelo and Gavicola, Rodolfo and Gerbaudo, Claudio and Gilli, Graciela and Giotto, Ana Paula and Godoy Bolzán, Pedro and Gomez Vilamajo, Oscar and Guerlloy, Fernando and Guridi, Cristian and Gutierrez Garrido, Narcisa and Hasbani, Eduardo and Hermida, Sonia and Hominal, Miguel and Hrabar, Adrian and ... and REWIND Investigators
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk... 
MEDICINE, GENERAL & INTERNAL | BASE-LINE | EVENTS | EFFICACY | SAFETY | PEPTIDE-1 RECEPTOR AGONISTS | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Elderly
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
by Gerstein, Hertzel C and Colhoun, Helen M and Dagenais, Gilles and Dagenais, Gilles R and Diaz, Rafael and Diaz, Sarahy and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Botros, Fady T and Riddle, Matthew C and Rydén, Lars and Xavier, Denis and Atisso, Charles Messan and Dyal, Leanne and Hall, Stephanie and Hall, Charles and Rao-Melacini, Purnima and Wong, Gloria and Avezum, Alvaro and Basile, Jan and Chung, Ming-Min and Chung, Namsik and Chung, Jin-Wook and Conget, Ignacio and Cushman, William C and Franek, Edward and Hancu, Nicolae and Hanefeld, Christoph and Hanefeld, Markolf and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Keltai, Katalin and Lanas, Fernando and Leiter, Lawrence A and Lopez-Jaramillo, Patricio and Cardona Munoz, Ernesto German and Pirags, Valdis and Pogosova, Nana and Raubenheimer, Peter J and Shaw, Jonathan E and Sheu, Wayne H-H and Temelkova-Kurktschiev, Theodora and Abella, Mercedes and Alebuena, Andrea and Almagro, Sandra and Amoroso, Eduardo and Anadon, Paula and Andreu, Elizabeth and Aristimuño, Guillermo and Arzadun, Maria and Barbieri, Maria and Barcudi, Raul and Bartolacci, Ines and Bolobanich, Gabriel and Bordonava, Anselmo and Bustamante Labarta, Miguel and Bustos, Betina and Caccavo, Alberto and Camino, Alejandra and Cantero, Maria and Carignano, Maria and Cartasegna, Luis and Cipullo, Marcela and Commendatore, Víctor and Conosciuto, Victoria and Costamagna, Osvaldo and Crespo, Claudia and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dean, Sofia and Dituro, Claudio and Dominguez, Andrea and Farah, Miguel and Fernandez, Alberto and Fernandez, Florencia and Ferrari, Adriana and Flammia, Patricia and Fuentealba, Jose and Gallardo, Karina Beatriz and Garcia, Mar and Garcia, Celso and Garcia, Maria and Garcia Duran, Ruben and Garrido, Marcelo and Gavicola, Rodolfo and Gerbaudo, Claudio and Gilli, Graciela and Giotto, Ana Paula and Godoy Bolzán, Pedro and Gomez Vilamajo, Oscar and Guerlloy, Fernando and Guridi, Cristian and Gutierrez Garrido, Narcisa and Hasbani, Eduardo and Hermida, Sonia and Hominal, Miguel and Hrabar, Adrian and ... and REWIND Investigators
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the... 
MEDICINE, GENERAL & INTERNAL | BASE-LINE | LIRAGLUTIDE | INCRETIN | CARDIOVASCULAR OUTCOMES | DISEASE | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
by Ray, Kausik K and Ray, Michael and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Budaj, Andrzej and Diaz, Rafael and Diaz, Ariel and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Jukema, J. Wouter and Jukema, Johan and Loizeau, Virginie and Lopes, Renato D and Lopes, Renato and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and White, Matthew and White, Lindsey and Zeiher, Andreas M and Schwartz, Steven and Schwartz, Michael and Schwartz, Gregory G and Steg, Philippe Gabriel and Steg, Ph. Gabriel and Tricoci, Pierluigi and Mahaffey, Kenneth W and Edelberg, Jay M and Lecorps, Guillaume and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Gotcheva, Nina N and Prieto, Juan-Carlos and Prieto, Juan C and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Roger and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Kazuo and Kimura, Takeshi and Kim, Sang-Hyun and Kim, Youngkwon and Kim, Chongjin and Kim, Hyo Soo and Kim, Hack-Lyoung and Kim, Moo Hyun and Kim, Hyo-Soo and Kim, Hae Young and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Karpov, Yuriy and Chua, Terrance and Fras, Zlatko and Dalby, Anthony J and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Moriarty, Patrick M and Moriarty, Katie and ... and ODYSSEY OUTCOMES Comm Investigato
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial
by O’Donoghue, Michelle L and Braunwald, Eugene and White, Harvey D and Steen, Dylan P and Lukas, Mary Ann and Tarka, Elizabeth and Steg, P. Gabriel and Hochman, Judith S and Bode, Christoph and Maggioni, Aldo P and Im, KyungAh and Shannon, Jennifer B and Davies, Richard Y and Murphy, Sabina A and Crugnale, Sharon E and Wiviott, Stephen D and Bonaca, Marc P and Watson, David F and Weaver, W. Douglas and Serruys, Patrick W and Cannon, Christopher P and SOLID-TIMI 52 Investigators
JAMA, ISSN 0098-7484, 09/2014, Volume 312, Issue 10, pp. 1006 - 1015
IMPORTANCE: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been hypothesized to be involved in atherogenesis through pathways related to inflammation.... 
MORTALITY | LIPOPROTEIN | CELLS | MEDICINE, GENERAL & INTERNAL | ISCHEMIC EVENTS | HEART-DISEASE | ACTIVATING-FACTOR ACETYLHYDROLASE | CARDIOVASCULAR OUTCOMES | MACROPHAGES | RISK | PHOSPHOLIPASE A | Blood Proteins - adverse effects | Myocardial Infarction - epidemiology | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Humans | Middle Aged | Kaplan-Meier Estimate | Myocardial Ischemia - prevention & control | Oximes - therapeutic use | Male | Secondary Prevention | Blood Proteins - therapeutic use | Incidence | Acute Coronary Syndrome - drug therapy | Benzaldehydes - adverse effects | Myocardial Infarction - drug therapy | Myocardial Ischemia - therapy | Cardiovascular Diseases - mortality | Female | Aged | Benzaldehydes - therapeutic use | Myocardial Ischemia - epidemiology | Complications and side effects | Development and progression | Care and treatment | Research | Acute coronary syndrome | Patient outcomes | Acute coronary syndromes | Cardiology | Medical treatment | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights